CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 125 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,998,000 | -37.0% | 262,400 | -21.6% | 0.20% | -44.6% |
| Q1 2018 | $9,522,000 | +7.7% | 334,680 | -20.1% | 0.37% | -4.2% |
| Q4 2017 | $8,838,000 | +27.2% | 418,680 | +9.5% | 0.38% | +12.0% |
| Q3 2017 | $6,946,000 | -35.8% | 382,271 | -45.3% | 0.34% | -48.0% |
| Q2 2017 | $10,825,000 | -8.1% | 698,392 | +2.4% | 0.66% | -13.7% |
| Q1 2017 | $11,776,000 | +53.7% | 681,892 | -2.2% | 0.76% | +15.8% |
| Q4 2016 | $7,660,000 | -31.6% | 696,992 | -2.5% | 0.66% | -25.9% |
| Q3 2016 | $11,206,000 | +49.5% | 714,692 | -2.6% | 0.89% | +24.4% |
| Q2 2016 | $7,497,000 | -20.4% | 733,899 | +0.6% | 0.72% | -25.6% |
| Q1 2016 | $9,413,000 | -34.7% | 729,699 | -1.2% | 0.96% | -10.7% |
| Q4 2015 | $14,405,000 | – | 738,356 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |